10 Gram	FOB Price: USD 10.0000

Min.Order :10 Gram
Purity: 99%
Payment Terms : T/T,Other

Keywords

Methanone,[6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-,hydrochloride (9CI) Bonebay Bontact

Quick Details

Appearance:raw powder
Application:bodybuilding
PackAge:bag
ProductionCapacity:100|Kilogram|Month
Storage:Ambient temperature, protected from light
Transportation:international express

Superiority:

Advantages of Hubei Cangsheng Trading Co., Ltd.

1. High-Purity Products, Uncompromised Quality

Leveraging cutting-edge purification technologies and stringent quality control systems, our core products achieve purity levels exceeding 99.99%, precisely meeting the demands of high-tech industries such as electronics, pharmaceuticals, and new energy. Intelligent monitoring ensures batch-to-batch consistency, backed by ISO 9001-certified processesthat align with global quality benchmarks.

2. China-Based Manufacturing, Integrated Supply Chain

As a proudly Chinese-manufactured brand, we harness domestic high-quality raw material suppliers and a mature industrial ecosystem to deliver cost efficiencyand agile production scalability. Fully automated production lines enable an annual capacity of metric tons, supporting large-scale orders while offering tailored R&D solutions for niche applications.

3. Rapid Global Delivery Network

Our strategically located facilities and partnerships with top-tier logistics providers ensure fast-tracked shippingto clients worldwide. Real-time tracking and optimized routes reduce standard delivery cycles by over 30%, minimizing downtime for time-sensitive industries.

4. Operational Excellence & Sustainability

AI-driven process optimization and lean management protocols maximize energy efficiencyand reduce waste. With a >95% on-time delivery rateand a carbon-neutral roadmap, we combine speed, reliability, and eco-conscious practices to drive value for global partners.

Why Choose Us?

? Precision purityfor mission-critical applications

? Cost-competitiveChina manufacturing edge

? Faster turnaroundwithout compromising quality

? End-to-end innovationfrom lab to logistics

Perfectly engineered for tomorrow’s challenges.

Details:

Raloxifene Hydrochloride cas:82640-04-8 Pharmaceutical Raw Materials

(raloxifene hydrochloride) is a selective estrogen receptor modulator (SERM) primarily used for the prevention and treatment of osteoporosis in postmenopausal women, as well as to reduce the risk of breast cancer in high-risk women.

Key information about Raloxifene hydrochloride:
Mechanism of action:

Raloxifene produces selective effects in different tissues by binding to estrogen receptors:

In bones, it plays a similar role to estrogen, helping to increase bone density and reduce fracture risk.

In the breast and uterus, it plays an anti-estrogen role, reducing breast cancer risk and not stimulating endometrial hyperplasia.

Main uses:

Osteoporosis: Used to prevent and treat osteoporosis in postmenopausal women and reduce the risk of spinal fractures.

Breast cancer prevention: used in high-risk postmenopausal women to reduce the risk of estrogen receptor-positive breast cancer.

How to use:

It is usually taken orally once a day at a dose of 60 mg.

It can be used with calcium and vitamin D supplements to enhance bone health.

Advantages:

It has a protective effect on bones while not increasing the risk of endometrial cancer (unlike some other estrogen therapies).

Can reduce the incidence of breast cancer in high-risk women.

Side effects:

Common side effects include hot flashes, leg cramps, joint pain and sweating.

Serious but rare side effects may include venous thromboembolism (such as deep vein thrombosis or pulmonary embolism).

Contraindications:

Contraindicated in women with a history of VTE.

It should not be used by pregnant women or women who may become pregnant because of possible harm to the fetus.

Note:

Bone density and health status should be monitored regularly during use.

Avoid prolonged bed stay or inactivity to reduce the risk of blood clots.